Contineum Therapeutics, Inc. (CTNM) Net margin
Contineum Therapeutics, Inc. (CTNM) net profit margin by fiscal year — reported net income divided by reported revenue.
45.4%FY2023
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | 45.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More CTNM financial trends
CTNM RevenueCTNM Net incomeCTNM Gross profitCTNM Gross marginCTNM Operating incomeCTNM Operating marginCTNM Operating cash flowCTNM Free cash flowCTNM Capital expendituresCTNM Return on equityCTNM Stock buybacksCTNM Dividends paidCTNM Total assetsCTNM Total liabilitiesCTNM Shareholders’ equityCTNM overview →